Stock listing
NASDAQ:AXLA Axcella Health Inc Stock
Follow Axcella Health Inc into a list and get an email when it puts out news.
Delisted NASDAQ:AXLA no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:AXLA
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
Axcella Health Inc on 6ix
- Calls
- 3 calls with a replay · 3 with a transcript · latest Nov 1, 2022
- Decks
- 6 decks · latest Sep 29, 2022
Events
| Call | When | Status |
|---|---|---|
| Axcella Health (AXLA) Q3 2022 Earnings Call | Tue, Nov 01, 2022 · 8:30 AM ET | Replay |
| Axcella Health (AXLA) Q2 2022 Earnings Call | Fri, Aug 12, 2022 · 8:00 AM ET | Replay |
| Axcella Health (AXLA) Q3 2020 Earnings Call | Thu, Nov 12, 2020 · 8:30 AM ET | Replay |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Technical Presentation (September 2022) | Technical | 62 slides | Sep 29, 2022 |
| Technical Presentation (August 2022) | Technical | 51 slides | Aug 2, 2022 |
| Investor Presentation (January 2022) | Investor deck | 36 slides | Jan 10, 2022 |
| Q1 2021 Earnings Presentation | Earnings | 31 slides | May 6, 2021 |
| Technical Presentation (August 2020) | Technical | 16 slides | Aug 5, 2020 |
| Technical Presentation (May 2020) | Technical | 23 slides | May 6, 2020 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Paul Sekhri Other companies: Apnimed, Inc. (Director · Since at least Jul 30, 2026); vTv Therapeutics Inc. (Chairman of the Board, President and Chief Executive Officer · Since at least Aug 1, 2022); Veeva Systems Inc. (Director · Since at least Jun 22, 2016); Longboard Pharmaceuticals Inc (Director · Mar 11, 2021 – Dec 2, 2024 · Past); BiomX Inc. (Director · Oct 2, 2020 – Jul 28, 2021 · Past); Enumeral Biomedical Holdings Inc (Director · Dec 9, 2016 – Dec 9, 2016 · Past); Alpine Immune Sciences Inc (Director · Sep 12, 2016 – Jan 2, 2020 · Past) | Director · May 19, 2022 – May 19, 2022 · Past |
| Catherine Angell Sohn Other companies: Maze Therapeutics, Inc. (Director · Since at least Jan 30, 2025); Altimmune, Inc. (Director · Since at least Mar 23, 2023); Rubius Therapeutics Inc (Director · Jul 17, 2018 – May 12, 2022 · Past); Palisade Bio, Inc. (Director · Jan 13, 2014 – Jul 1, 2015 · Past); Lifecore Biomedical, Inc. (Director · Nov 13, 2012 – Jun 4, 2022 · Past); Jazz Pharmaceuticals plc (Director · Jul 27, 2012 – Aug 11, 2023 · Past) | Director · Aug 21, 2019 – May 19, 2022 · Past |
| Michael Rosenblatt Other companies: Azenta, Inc. (Director · Sep 4, 2018 – Feb 12, 2024 · Past); Rubius Therapeutics Inc (Director · Jul 17, 2018 – May 12, 2022 · Past); Merck & Company, Inc. (Exec V-P & Chief Med Officer · Dec 16, 2009 – May 10, 2016 · Past) | Director · May 19, 2022 – May 19, 2022 · Past |
| Christopher A. Viehbacher Other companies: Braveheart Bio, Inc. (Director · Since at least Aug 5, 2026); Biogen Inc. (President and Chief Executive Officer · Since at least Nov 14, 2022) | Director · May 8, 2019 – May 8, 2019 · Past |
| Gary P Pisano Other companies: Patheon N.V. (Director · Jul 20, 2016 – Aug 29, 2017 · Past); Sio Gene Therapies Inc (Director · May 13, 2016 – Apr 28, 2017 · Past) | Director · May 8, 2019 – May 19, 2022 · Past |
| Gregory Behar Other companies: Aimmune Therapeutics Inc (Director · Nov 23, 2016 – Oct 13, 2020 · Past); Seres Therapeutics, Inc. (Director · Jun 25, 2015 – Jun 22, 2023 · Past) | Director · May 8, 2019 – May 20, 2021 · Past |
| Margaret Koziel Other companies: Innoviva, Inc. (Chief Medical Officer · Jul 31, 2023 – Jul 31, 2023 · Past) | Chief Medical Officer · Dec 1, 2021 – Mar 1, 2023 · Past |
| Shane Maltbie Other companies: Hillevax Inc (Chief Financial Officer · Since at least Jan 6, 2023) | See Remarks · Aug 21, 2019 – Aug 21, 2019 · Past |
| Shreeram Aradhye Other companies: Dicerna Pharmaceuticals Inc (EVP & Chief Medical Officer · Sep 8, 2020 – Dec 28, 2021 · Past) | Director · May 22, 2019 – May 20, 2021 · Past |
| Torben Straight Nissen Other companies: Rubius Therapeutics Inc (President · Jul 17, 2018 – Jul 24, 2019 · Past) | Director · Oct 10, 2022 – Nov 16, 2022 · Past |
All 16 people
| Person | Seat |
|---|---|
| Alison D Schecter | President - Research & Dev. · Mar 15, 2021 – Feb 8, 2022 · Past |
| CRISTINA Rondinone | Director · May 8, 2019 – May 19, 2022 · Past |
| Paul Fehlner | SVP & Chief Legal Officer · May 8, 2019 – Feb 17, 2023 · Past |
| Robert Crane | Chief Financial Officer · Feb 8, 2022 – Mar 16, 2022 · Past |
| Tony Tramontin | SVP & Chief Scientific Officer · May 8, 2019 – Dec 18, 2019 · Past |
| William Hinshaw | President & CEO, Director · Sep 29, 2020 – Feb 17, 2023 · Past |
Log in to ask 6ix AI your own questions about Axcella Health Inc.